These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34299942)

  • 1. The Effect of Vaccination Rates on the Infection of COVID-19 under the Vaccination Rate below the Herd Immunity Threshold.
    Chen YT
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming COVID-19 in West African countries: is herd immunity an option?
    Ilesanmi OS; Akande A; Afolabi AA
    Pan Afr Med J; 2020; 35(Suppl 2):103. PubMed ID: 33282058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
    Jeremijenko A; Chemaitelly H; Ayoub HH; Alishaq M; Abou-Samra AB; Al Ajmi JAAA; Al Ansari NAA; Al Kanaani Z; Al Khal A; Al Kuwari E; Al-Mohammed A; Al Molawi NHA; Al Naomi HM; Butt AA; Coyle P; El Kahlout RA; Gillani I; Kaleeckal AH; Masoodi NA; Thomas AG; Nafady-Hego H; Latif AN; Shaik RM; Younes NBM; Rahim HFA; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R; Abu-Raddad LJ
    Emerg Infect Dis; 2021 May; 27(5):1343-1352. PubMed ID: 33900174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Great Expectations of COVID-19 Herd Immunity.
    Giurgea LT; Morens DM
    mBio; 2022 Feb; 13(1):e0349521. PubMed ID: 35073740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forecasting the SARS COVID-19 pandemic and critical care resources threshold in the Gulf Cooperation Council (GCC) countries: population analysis of aggregate data.
    Al-Aamri AK; Al-Harrasi AA; AAl-Abdulsalam AK; Al-Maniri AA; Padmadas SS
    BMJ Open; 2021 May; 11(5):e044102. PubMed ID: 33980523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling COVID-19 dynamics and potential for herd immunity by vaccination in Austria, Luxembourg and Sweden.
    Kemp F; Proverbio D; Aalto A; Mombaerts L; Fouquier d'Hérouël A; Husch A; Ley C; Gonçalves J; Skupin A; Magni S
    J Theor Biol; 2021 Dec; 530():110874. PubMed ID: 34425136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But Plausibile.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(4):e170122200309. PubMed ID: 35040409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World.
    Cihan P
    Appl Soft Comput; 2021 Nov; 111():107708. PubMed ID: 34305491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of a vaccine against COVID-19 - a systematic review of surveys conducted worldwide.
    Snehota M; Vlckova J; Cizkova K; Vachutka J; Kolarova H; Klaskova E; Kollarova H
    Bratisl Lek Listy; 2021; 122(8):538-547. PubMed ID: 34282618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.